Salta al contenuto principale
Passa alla visualizzazione normale.

GRAZIA PENNISI

Pubblicazioni

Data Titolo Tipologia Scheda
2024 SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease Articolo in rivista Vai
2024 Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease Articolo in rivista Vai
2024 Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in individuals with steatotic liver disease Articolo in rivista Vai
2024 ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization Articolo in rivista Vai
2024 Diagnostic accuracy of AGILE 3+ score for advanced fibrosis in patients with NAFLD: A systematic review and meta-analysis Articolo in rivista Vai
2024 Prevalence and Determinants of Liver Disease in Relatives of Italian Patients With Advanced MASLD Articolo in rivista Vai
2024 An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD) Articolo in rivista Vai
2024 Corrigendum to “SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease” [J Hepatol 80 (2024) 10-19, (S0168827823051474), (10.1016/j.jhep.2023.09.020)] Nota o commento Vai
2024 Correction to: Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women (Nature Medicine, (2023), 29, 10, (2643-2655), 10.1038/s41591-023-02553-8) Nota o commento Vai
2024 Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease Articolo in rivista Vai
2024 Risk of liver-related events in metabolic dysfunction-associated steatohepatitis (MASH) patients with fibrosis: A comparative analysis of various risk stratification criteria Articolo in rivista Vai
2024 Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease Articolo in rivista Vai
2024 Mitochondrial amidoxime-reducing component 1 p.Ala165Thr increases protein degradation mediated by the proteasome Articolo in rivista Vai
2024 Evaluation of ChatGPT as a Counselling Tool for Italian-Speaking MASLD Patients: Assessment of Accuracy, Completeness and Comprehensibility Articolo in rivista Vai
2024 Performance of ultrasound-guided attenuation parameter and 2D shear wave elastography in patients with metabolic dysfunction-associated steatotic liver disease Articolo in rivista Vai
2024 Clinical outcomes of MAFLD versus NAFLD: A meta-analysis of observational studies Articolo in rivista Vai
2024 Are we ready for genetic testing in metabolic dysfunction-associated steatotic liver disease? Review essay (rassegna critica) Vai
2024 The PD-1/PD-L1 Axis in the Biology of MASLD Review essay (rassegna critica) Vai
2023 Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation study Articolo in rivista Vai
2023 Impact of PNPLA3 rs738409 Polymorphism on the Development of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease Articolo in rivista Vai
2023 MAFLD: a multisystem disease Recensione in rivista Vai
2023 Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis Articolo in rivista Vai
2023 Point-of-Care Noninvasive Prediction of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease Articolo in rivista Vai
2023 Inflammation and autonomic balance in cirrhosis: Association between sympathetic nervous system and osteopontin, interleukin-22, interleukin-6 and interleukin-1Ra concentrations according to portal hypertension and disease severity Articolo in rivista Vai
2023 Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease Articolo in rivista Vai
2023 Heart rate variability is associated with disease severity and portal hypertension in cirrhosis Articolo in rivista Vai
2023 Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women Articolo in rivista Vai
2023 Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease Articolo in rivista Vai
2023 Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes Articolo in rivista Vai
2022 RESIST-HCV Criteria to Monitor Progression of Low-Risk Esophageal Varices in Patients With Compensated Cirrhosis After HCV Eradication: The SIMPLE Study: SIMPLE: Scoring Index to Monitor Progression of Low-risk Esophageal varices Articolo in rivista Vai
2022 A cholestatic pattern predicts major liver-related outcomes in patients with non-alcoholic fatty liver disease Articolo in rivista Vai
2022 AGILE 3+ Score for the Diagnosis of Advanced Fibrosis and for Predicting Liver-related Events in NAFLD Articolo in rivista Vai
2022 Liver-related and extrahepatic events in patients with non-alcoholic fatty liver disease: a retrospective competing risks analysis Articolo in rivista Vai
2022 Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: Time for reappraisal of BMI-driven approach? Articolo in rivista Vai
2022 A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease Articolo in rivista Vai
2022 Effect of pharmacological interventions and placebo on liver Histology in nonalcoholic steatohepatitis: A network meta-analysis Articolo in rivista Vai
2021 Impact of direct-acting antivirals (DAAs) on cardiovascular diseases in patients with chronic hepatitis C Articolo in rivista Vai
2021 THE ROLE OF TRANSIENT ELASTOGRAPHY IN NAFLD Capitolo o Saggio Vai
2021 Interplay between non-alcoholic fatty liver disease and cardiovascular risk in an asymptomatic general population Articolo in rivista Vai
2021 Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver disease Articolo in rivista Vai
2021 Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease Articolo in rivista Vai
2021 Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease Articolo in rivista Vai
2021 NR1H4 rs35724 G>C variant modulates liver damage in nonalcoholic fatty liver disease Articolo in rivista Vai
2020 Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease Articolo in rivista Vai
2020 The relevance of noninvasive tools to assess fibrosis in non-alcoholic fatty liver disease Articolo in rivista Vai
2020 Biochemical biomarkers of NAFLD/NASH Capitolo o Saggio Vai
2020 IMPACT OF NON-ALCOHOLIC FATTY LIVER DISEASE ON CARDIOVASCULAR RISK IN A GENERAL POPULATION Abstract in atti di convegno pubblicato in rivista Vai
2020 PCSK9 rs11591147 R46L loss-of-function variant protects against liver damage in individuals with NAFLD Articolo in rivista Vai
2020 Neurotensin up-regulation is associated with advanced fibrosis and hepatocellular carcinoma in patients with MAFLD Articolo in rivista Vai
2020 PNPLA3 rs738409 C>G Variant Predicts Fibrosis Progression by Noninvasive Tools in Nonalcoholic Fatty Liver Disease Articolo in rivista Vai
2020 Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease Articolo in rivista Vai
2019 Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis Articolo in rivista Vai
2019 IMPACT OF NON-ALCOHOLIC FATTY LIVER DISEASE ON CARDIOVASCULAR RISK IN A GENERAL POPULATION Abstract in atti di convegno pubblicato in rivista Vai
2019 Pharmacological therapy of non-alcoholic fatty liver disease: What drugs are available now and future perspectives Articolo in rivista Vai
2019 The burden of hepatocellular carcinoma in non-alcoholic fatty liver disease: Screening issue and future perspectives Articolo in rivista Vai
2018 Antidiabetic drugs in NAFLD: The accomplishment of two goals at once? Articolo in rivista Vai